No Detail Found!

Breakthrough covid-19 infections - analyzing our experience

Author(s)
Aneela Hussain Infectious diseases Department, HIV Clinic Indus Hospital & Health Network, Korangi Crossing, Karachi, Pakistan.
Samreen Sarfaraz Indus Hospital & Health Network, Karachi, Pakistan.
Sabiha Anis Indus Hospital & Health Network, Karachi, Pakistan.
Quratulain Sheikh Indus Hospital & Health Network, Karachi, Pakistan.
Anum Rahim Indus Hospital & Health Network, Karachi, Pakistan.
Shameem Behram Indus Hospital & Health Network, Karachi, Pakistan.
Rabeea Shah Indus Hospital & Health Network, Karachi, Pakistan.
Owais Khan Indus Hospital & Health Network, Karachi, Pakistan.
Abstract
Objective: There are many cases of post-vaccination COVID-19 globally. Also, literature on serum antibodies after vaccination is abundant. Our research focuses on breakthrough infections reported at our institution during the third wave of COVID-19. Methods: A total of 177 people recruited at the Indus Hospital Karachi between May to September 2021 with COVID-19 infection were divided into vaccinated, partially vaccinated, and unvaccinated cohorts. Furthermore, a subset of the vaccinated cohort was tested for anti-NP and anti-S antibodies. Results: There were 119 patients with breakthrough infection, however, 74% had mild symptoms. The antibodies against NP and S were found at a higher level in those who had a breakthrough infection in comparison to healthy vaccinated controls. Conclusion: Vaccination does not prevent disease but does confer some immunity causing less severe infection.
Publication Details
Page(s) 1225-1231
Published Journal: Pakistan Journal of Medical Sciences, Volume: 39, Issue: 5, Year: 2023

Request the full text from PASTIC

Keywords
COVID-19, clinical characteristics, Covid-19, Breakthrough infections, Ant-COVID-IgG antibodies
0

Citations

0

Downloads

100

Views